Joint Clinical Assessment report on tovorafenib (Ojemda) + +

https://health.ec.europa.eu/publications/joint-clinical-assessment-report-tovorafenib-ojemda_en HTA Regulation Last month, EURORDIS released an evaluation of the first EU Joint Clinical Assessment (JCA) report on tovorafenib, published by the European Commission under the Health Technology Assessment (HTA) Regulation. By developing a scoring grid and drawing on input from an evaluation group of patient advocates, EURORDIS identified areas for improvement in future JCA reports and provided recommendations on structure, contributors and scientific content.. https://www.eurordis.org/eurordis-members-score-the-first-eu-joint-clinical-assessment-report/